News
China just banned the latest deadly opioid. SF drug users still want it
Summary by The San Francisco Editorial Desk David Sjostedt , as published by The San Francisco Standard
· October 8, 2026
· 1 min read
Photo: The San Francisco Standard · view original
Story provenance No corrections
Summary created by The San Francisco Editorial Desk — automated, rule-governed Byline on source page David Sjostedt, as published by The San Francisco Standard Original story Read at the source Source published Oct 8, 2026 Indexed here Oct 8, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log · Publisher’s note
Key points Despite its lethal nature, cychlorphine's danger is actually a draw for some users. A recently banned opioid in China is still in demand by some drug users.
A recently banned opioid in China is still in demand by some drug users. The opioid, known as cychlorphine, has been linked to deadly outcomes.
Despite its lethal nature, cychlorphine's danger is actually a draw for some users. The allure of the drug's potency appears to outweigh its risks for these individuals.
Further information on this development is available from the source, which reports on the ongoing demand for cychlorphine among some drug users, undeterred by its banned status and lethal effects.
More News Today’s briefing Local events
Why this story is here
The San Francisco Standard reported and published this story. The San Francisco selected it, summarised the key facts above, and links to the original. We did not report this story and we added no reporting of our own to it.
About this story
As published by The San Francisco Standard . The San Francisco selects stories from publishers’ feeds, summarises them, and links back to the publisher that reported them. We add no reporting of our own. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit The San Francisco Standard . Have a tip or correction? Contact the editor .
Category: News Published: October 8, 2026 Source: The San Francisco Standard Reading time: 1 min
Frequently asked about this story
What is this story about? A recently banned opioid in China is still in demand by some drug users. The opioid, known as cychlorphine, has been linked to deadly outcomes. Despite its lethal nature, cychlorphine's danger is…
When was this published? This article was first published on October 8, 2026 by The San Francisco Standard and curated for The San Francisco readers.
Who reported this story? This story was reported by David Sjostedt at The San Francisco Standard. To learn more about how The San Francisco selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more News coverage from The San Francisco, or browse our daily briefing and topic hubs .
← Back to all news
More News →
Today’s briefing
Subscribe to newsletter
